Stockreport

Adamis Pharmaceuticals Announces Patent Litigation Regarding Its Higher Dose Naloxone Injection Product

Adamis Pharmaceuticals Corporation  (ADMP) 
Last adamis pharmaceuticals corporation earnings: 11/12 04:16 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.adamispharmaceuticals.com/investor-overview
PDF SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Adamis Pharmaceuticals Corporation (NASDAQ: ADMP) today announced that on May 20, 2019, it received notice that it had been [Read more]